id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-D-2214-0002,FDA,FDA-2020-D-2214,Dry Eye: Developing Drugs for Treatment; Guidance for Industry; DRAFT GUIDANCE,Other,Guidance,2020-12-17T05:00:00Z,2020,12,2020-12-17T05:00:00Z,,2024-11-12T23:26:26Z,,1,0,09000064849a5c06
FDA-2020-D-2214-0001,FDA,FDA-2020-D-2214,Dry Eye: Developing Drugs for Treatment; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2020-12-17T05:00:00Z,2020,12,2020-12-17T05:00:00Z,2021-03-18T03:59:59Z,2022-09-12T19:47:56Z,2020-27762,0,0,09000064849a4491